Wang, F., Yuan, Y., Wang, L., Ye, X., Zhao, J., Shen, M., . . . Sun, X. One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial. Wiley.
Chicago Style (17th ed.) CitationWang, Fenghua, et al. One-Year Outcomes of 1 Dose Versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial. Wiley.
MLA (9th ed.) CitationWang, Fenghua, et al. One-Year Outcomes of 1 Dose Versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial. Wiley.
Warning: These citations may not always be 100% accurate.